Lab to Market: Bridging the Gap
In recent years, the nexus between academia and industry has become
increasingly pronounced, ushering in a new era where groundbreaking
research in healthcare is not only valued for its scientific merit
but also for its potential commercial applications. The
commercialization of academic research in healthcare represents a
dynamic intersection where innovative ideas cultivated in the
hallowed halls of academia are transformed into tangible products,
therapies, and technologies that have the power to revolutionize the
healthcare landscape.
Traditionally, academic research has been driven by a pursuit of
knowledge and a commitment to advancing human understanding.
However, as the global healthcare challenges escalate, there is a
growing recognition of the need to translate these academic
discoveries into real-world solutions that can improve patient
outcomes, enhance medical treatments, and address unmet healthcare
needs. The commercialization of academic research offers a strategic
pathway to bridge the gap between scientific discovery and practical
application, fostering a symbiotic relationship between the realms
of academia and industry.
This paradigm shift is fueled by several factors, including the
increasing demand for innovative healthcare solutions, the rising
costs and complexities associated with research and development, and
the desire to accelerate the pace at which novel therapies reach
patients. As universities and research institutions embrace a more
entrepreneurial mindset, collaborations with industry partners, the
establishment of spin-off companies, and the licensing of
intellectual property have become integral components of the
academic research ecosystem.
In this era of unprecedented scientific advancement, the
commercialization of academic research in healthcare stands as a
transformative force, propelling scientific discoveries from
laboratory benches to the forefront of patient care.
Creating Value
For Healthcare
Rapid Scaling
Global Health Impact
mproved Patient
Outcomes
Regulatory Compliance and Quality Assurance
Faster Translation
of Discoveries
Addressing Unmet
Need
For Researchers
Intellectual Property
Protection
Innovation Diffusion
Industry-driven
Research
Feedback Loop for Research Improvement
Knowledge
Transfer
Sustainable Funding
Model
For Academia
Resource Mobilization
Global Competitiveness
Cross-Disciplinary
Collaboration
Industry-Academia
Collaboration
Economic Growth
and Job Creation
Industry-Academia
Collaboration
Beyond the Lab
In the dynamic realm of healthcare innovation, Invitreo stands as
a beacon of transformation, bridging the gap between academic
research and real-world applications. Specializing in the
commercialization of cutting-edge discoveries, Invitreo is at the
forefront of pioneering advancements in healthcare, with a
particular emphasis on medical devices.
At its core, Invitreo is dedicated to translating the wealth of
knowledge generated in academic institutions into tangible
solutions that have a meaningful impact on patient well-being. By
strategically focusing on bioprinting and regenerative medicine,
the company exemplifies a commitment to pushing the boundaries of
medical science, offering innovative approaches to address the
complex challenges in healthcare.
Invitreo is distinguished not only by its ability to navigate the
complex intersection of academia and industry but also by its
unwavering commitment to fostering collaborative relationships
with leading research institutions. The company serves as a
catalyst, propelling groundbreaking academic research from the
laboratory to the market, where it can make a tangible difference
in patient outcomes.
As the healthcare landscape continues to evolve, Invitreo emerges
as a dynamic force, driving the commercialization of academic
research and paving the way for a new era in medical device
innovation. With a vision firmly rooted in innovation and a
mission to bring transformative solutions to the forefront of
healthcare, Invitreo stands poised to shape the future of medical
advancements
SDG Impact
Commercializing healthcare research drives multiple SDGs
Yields new drugs, devices, and therapies, enhancing diagnosis, treatment, and prevention. Reduce mortality and morbidity rates and strengthen health systems through reinvestment.
Creates jobs in R&D, manufacturing, and distribution, fueling economic growth and entrepreneurship. It attracts investment, enhances global competitiveness, and boosts export potential.
Spurs private investment in R&D, driving innovation for new treatments and technologies. It leads to advanced medical tools, promotes knowledge sharing, and accelerates scientific discovery.
Affordable over time, benefiting low-income communities. Incentivizes research into neglected diseases, fosters public-private partnerships, and empowers local capacity building.
COVID Impact
Accelerated Innovation
COVID-19 urgency has sped up healthcare research and innovation, emphasizing rapid development and commercialization of diagnostics, treatments, and vaccines.
Enhanced Collaboration
Pandemic response highlights the importance of collaboration between governments, academia, industry, and organizations, facilitated by commercialization.
Addressing Inequities
Commercialization can mitigate health disparities by improving access to affordable healthcare solutions, especially for vulnerable communities.
Economic Stimulus
Commercialization drives economic recovery by generating investment, jobs, and innovation in healthcare sectors.
Building Resilient Systems
Investing in commercialized healthcare research strengthens healthcare systems by promoting innovative solutions for effective crisis management.
Challenges in Commercializing Research
Due to the complex nature of the healthcare industry and unique
characteristics of medical
innovations,
only about 5%-10% of academic discoveries in healthcare are
commercialized.
Long Development Timelines
due to extensive research, development, and regulation.
Stringent Regulatory Requirements
extending commercialization timelines and increasing costs
High Failure Rates
as many fail to meet clinical, regulatory, or market demands despite substantial investment
Costly Clinical Trials
particularly challenging for small companies and academic researchers.
Market Access Challenges
due to complex healthcare systems and policies.
Intellectual Property Issues
due to complex and costly nature involving patents and infringement concerns.
Market Uncertainty
due to healthcare market's dynamic nature, requires thorough analysis and strategic planning.
Interdisciplinary Collaboration
across diverse fields, requiring coordination and alignment of interests is important for success yet hard top achieve.
Invitreo Advantage
Partnerships
We partner with top academic institutions to
identify discoveries with commercial potential
Evaluation & Due Diligence
Our experienced team rigorously evaluates
research projects for commercial viability.
Licensing and IP Management
We protect and manage intellectual property
to maximize value for all parties involved
Fundraising
We secure funding for commercialization by
connecting with VC firms, angel investors,
and other funding sources.
Product Development Support
We offer comprehensive support throughout
the product development lifecycle
Regulatory & Compliance
Our regulatory experts navigate innovators
through complex regulations, ensuring
compliance with laws and standards.
Commercialization Strategy
Tailored commercialization plans based on
thorough market analysis
Market Launch & Distribution
We facilitate successful market launch and
distribution by leveraging our network
of industry
partners, distributors, and
healthcare providers
Contact Us
Singapore
Invitreo Biosciences Pte. Ltd.
160 Robinson Road #24-09
SBF Center, Singapore 068914
Email: info@invitreo.com
Social Impact
Commercializing healthcare research drives multiple SDGs
Improved Access to Healthcare
Promotes new drugs, devices, and treatments,
improving healthcare access in underserved areas
and reducing health disparities.
Empowerment through Knowledge
Academic, industry, and healthcare collaboration
shares knowledge, empowering professionals
to provide evidence-based care and enabling patients
to manage their health actively.
Enhanced Health Outcomes
Cutting-edge healthcare products from commercial
research enhance disease management,
lower mortality, and improve quality of life
for individuals and communities.
Global Health Diplomacy
Promotes global collaboration,
sharing resources & technologies to tackle health challenges and
achieve common goals.
Economic Opportunities
Drives investment, job growth, and entrepreneurship in biotech, pharma,
and medical devices, bolstering economic prosperity and livelihoods.